Johnson & Johnson is one of the leading healthcare companies in the world, with over one billion people using its products daily. The company has a well-diversified global footprint with the US accounting for 50% of the company’s revenues, and international markets constituting the remaining 50%.
The company offers the world’s largest range of consumer healthcare products and a comprehensive portfolio of surgical technology and specialty solutions. It is a global leader in seven consumer categories and owns a strong portfolio of iconic brands.
Some of its top selling and well-known brands include Neutrogena, Aveeno, Listerine, Tylenol, Motrin, and Zyrtec. Johnson & Johnson operates through an extensive distribution network, product portfolio, and a huge customer base. It is one of the most reputed healthcare organizations in the world and has developed a deep understanding of its customers’ needs with more than a century’s old experience.
Key Investment Data
- Ticker: nyse:jnj
- Sector: Healthcare
- Industry: Drug Manufacturers - General
- Market Cap: 412.96B
- Market Cap Group: Mega Cap
- P/E: 15.63
- Dividend Yield: 3.00%
- Grade: A
- Dividend Aristocrat: YES
- Chowder Score: Members Only
- Revenue Growth: Members Only
- Dividend Growth: Members Only
- Dividend Growth Fit: 6/10
- Dividend Income Fit: 8/10
Competitors
The competitive landscape is important as they compete for the same business. Below is the list of competitors in the same industry. While not displayed, a number of metrics you can also use to evaluate your picks are the Chowder Score, the Relative Strength Index (RSI), the Graham Number, and the Piotroski F-Score.
Ticker | Ticker | Company | Market Cap | P/E | Yield | Aristocrat | Graph | SectorID | IndustryID |
---|---|---|---|---|---|---|---|---|---|
LLY | NYSE:LLY | Lilly | 419.94 | 63.74 | 1.02 | NO | 1 | 8 | 35 |
JNJ | NYSE:JNJ | Johnson & Johnson | 412.96 | 15.63 | 3.00 | YES | 1 | 8 | 35 |
MRK | NYSE:MRK | Merck & Co., Inc. | 293.05 | 17.14 | 2.53 | NO | 1 | 8 | 35 |
ABBV | NYSE:ABBV | AbbVie Inc | 256.02 | 11.09 | 4.08 | YES | 1 | 8 | 35 |
PFE | NYSE:PFE | Pfizer Inc. | 207.58 | 5.94 | 4.46 | NO | 1 | 8 | 35 |
BMY | NYSE:BMY | Bristol Myers Squibb Co. | 138.32 | 8.45 | 3.46 | NO | 1 | 8 | 35 |
AMGN | NASDAQ:AMGN | Amgen Inc. | 119.38 | 12.83 | 3.81 | NO | 1 | 8 | 35 |
GILD | NASDAQ:GILD | Gilead Sciences Inc. | 98.35 | 12.09 | 3.80 | NO | 1 | 8 | 35 |
DHT.UN | TSE:DHT.UN | DIR Healthcare Trust | 0.36 | 0.00 | 4.17 | NO | 1 | 8 | 35 |
Top Picks by Bay Street Experts
Expert stock analysts have shared their opinions, and sometimes prediction, on the company.
For more top picks from stock analysts on Bay Street, check the full list of top picks by expect stock analysts from investment and asset management firms.
Not all analysts are equal and they don't cover the same type of stocks. The analysts performance and ownership is tracked for comparison.
Johnson & Johnson - FAQ
What is the stock ticker for Johnson & Johnson?
The stock ticker for Johnson & Johnson is NYSE:JNJ.
Is Johnson & Johnson a good stock to buy?
You need to consider your investment strategy and how NYSE:JNJ can fit in your portfolio.
The current dividend income score of 8/10 and dividend growth score of 6/10. Those 2 metrics together should help you decide the fit for your portfolio. Be it for income or for growth.
Is Johnson & Johnson a Buy, Sell or Hold?
The Dividend Snapshot Opportunity Score of 72 out of 100.
The score reflects the strength of a buy signal but it does not show a sell signal if it's low. The higher the better.
A sell signal is more difficult as it often relies on the reason you bought the stock in the first place.
How can I buy stocks for Johnson & Johnson?
You can easily buy the JNJ stock with an online trading platform.
Just make sure the stock fits your risk profile and investment goals.